|
Oxford, UK – 21 March 2014: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: Oxford Biomedica), the leading gene-based biopharmaceutical company, announces that John Dawson, Chief Executive Officer, will present at the 2nd Annual Regen Med Investor Day to be held Wednesday, March 26, 2014 in New York City. Organized by the Alliance for Regenerative Medicine (ARM) in partnership with leading financial firms Maxim Group and Piper Jaffray, this one-day investor conference focuses exclusively on the regenerative medicine and advanced therapies sector. The event includes clinical and commercial experts who will be on-hand to address specific questions regarding the outlook for the industry, as well as offer insight into how regenerative medicine products could impact the standard of care in key therapeutic areas. The program will include talks by key opinion leaders in the industry, life science investment experts and analysts as well as presentations by more than 30 leading companies from across the globe. The following are specific details regarding Oxford BioMedica’s presentation: Event: ARM’s Regen Med Investor Day Date: March 26, 2014 Time: 2:45pm Location: Metropolitan Club, One East 60th Street, New York, NY 10022 A live-streaming webcast of all panels and company presentations will be available at: https://www.arminvestorday.com/webcast and will be published on the event’s website shortly after the conference. Attendance at this event is for credentialed investors and members of the media only. If you are interested in attending, please contact Laura Parsons at lparsons@alliancerm.org. Please visit https://www.arminvestorday.com for more information. – Ends – |